Compound ID | 2185
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | DNA synthesis inhibitor. Inhibits the DNA gyrase (GyrAB) and topoisomerase IV (ParCE); bacterial topoisomerase inhibitor |
| Propensity to select resistant mutants: | Yes |
| Description: | Synthetic compound; optimised from a series of compounds that incorporates features based on fluoroquinolones and Pfizer's quinazolinediones |
| Year first mentioned: | 2022 |
| Development status: | Experimental |
| External links: | |
| Citations: |
|